Semaglutide
Long-acting GLP-1 receptor agonist research compound with 94% homology to native GLP-1.
From · per box of 10 vials
$45
Dual GLP-1/glucagon receptor agonist research compound.
Survodutide is a dual GLP-1/glucagon receptor agonist researched for metabolic and hepatic lipid studies. For laboratory research use only.
GLP-1 agonism drives insulinotropic signaling while glucagon agonism increases energy expenditure.
Early-stage trial data show promising weight loss and liver fat reduction outcomes in research settings.
For laboratory research use only. Dual-receptor agonist with potent metabolic effects.
From $355
per box of 10 vials
| Code | Dose | Price (USD) | Actions |
|---|---|---|---|
| SUR10 | 10 mg | $355 |
Research Use Only: All products are strictly intended for laboratory research and scientific analysis only. Not for human consumption, clinical use, or diagnostic applications.
Long-acting GLP-1 receptor agonist research compound with 94% homology to native GLP-1.
From · per box of 10 vials
$45
First-in-class dual GIP/GLP-1 receptor agonist for metabolic research.
From · per box of 10 vials
$55
Triple agonist (GLP-1, GIP, glucagon) research compound for metabolic studies.
From · per box of 10 vials
$100
Triple agonist (GLP-1, GIP, glucagon) research compound for metabolic studies — box of 10 vials.
From · per box of 10 vials
$180